Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
4
×
fda
4
×
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
4
×
wisconsin top stories
agios pharmaceuticals
life sciences
regeneron pharmaceuticals
sanofi
abeona therapeutics
affordable care act
alirocuma
alzheimer's
ameet nathwani
arches
biotech
bristol-myers squibb
cancer
clinical trials
What
american
4
×
roundup
based
best
bio
continue
crash
debate
healthcare
industry
kind
meeting
nash
people
pharmaceutical
policy
politicians
pressure
scalps
society
trump’s
u.s
ahead
ambien
annual
asco
ash
attendees
attention
big
biotech
blood
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
Language
Current search:
american
×
fda
×
" texas blog main "
×
" detroit top stories "
×
" wisconsin blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More